Medical Treatments
56 articles on Medical Treatments, researched and written by the Shotlee Editorial Team from primary sources.
The Billion-Dollar Problem Limiting Access to Ozempic, Wegovy, and Zepbound
Despite clinical evidence highlighting the significant health benefits and cost-effectiveness of GLP-1 medications such as Ozempic, Wegovy, and Zepbound, many insurance plans continue to impose restrictions on patient access. This article delves into the financial and practical barriers, as well as the profound consequences for individuals seeking these transformative treatments.
7 min read
Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising Claims in Legal Battle
Novo Nordisk has filed a lawsuit against Eli Lilly in the U.S. District Court for the District of New Jersey, alleging false advertising regarding GLP-1 weight loss medications.
7 min read
GLP-1s for Teen Weight Loss: A New Treatment Trend?
GLP-1 medications are rapidly changing obesity care for teens and young adults, with a notable shift away from bariatric surgery. This article delves into the latest research, potential benefits, and important considerations for this emerging trend.
7 min read
Plus-Size Swimsuit Model on Inclusivity Amidst GLP-1 Medications
Plus-size model Hunter McGrady shares her concerns about a perceived decline in fashion inclusivity, particularly in the context of the growing popularity of GLP-1 weight loss medications.
7 min read
Amy Schumer Highlights C-Section Scar After Weight Loss Journey: 'I'm a Warrior'
Amy Schumer, known for her candidness, recently shared a powerful image highlighting her C-section scar, a testament to her strength and resilience throughout her health and weight loss journey.
6 min read
What is the viral 'natural Ozempic' drink?
A viral trend promoting a 'natural Ozempic' drink made with gelatin and water is circulating on social media. This article delves into what the drink is, its purported benefits, and the expert opinions on its role in weight management.
6 min read
Dr. Oz Links Obesity to Chronic Disease Surge, Suggests GLP-1s Can 'Jumpstart' Better Health
CMS Administrator Dr. Oz highlights the critical link between obesity and chronic diseases, advocating for the strategic use of GLP-1 medications to improve health and potentially cut healthcare costs.
7 min read
Yes, GLP-1s Make You Thinner. But Do They Make You Freer?
While GLP-1 drugs like Ozempic and Wegovy offer significant medical benefits, their rise raises critical questions about freedom, body image, and the cultural pressure to be thinner.
8 min read
Beyond the Hype: Psyllium Husk for Gut Health and More
Often hailed as 'nature's Ozempic,' psyllium husk is a fiber-rich supplement gaining traction for its wide-ranging health benefits. But does it live up to the buzz? This article dives into the evidence for its impact on gut health, cholesterol, blood sugar, and weight management.
8 min read
Beyond the Hype: Understanding Peptides for Weight Loss and Health
Curious about peptides and their role in weight loss, cholesterol management, and overall health? This article breaks down what peptides are, how they work, and what the science says about popular options like GLP-1 agonists.
7 min read
Ozempic, Wegovy, Mounjaro: The GLP-1 Revolution in Weight Loss
A closer look at the groundbreaking GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, and their transformative effects on weight management and overall health.
6 min read
Illegal Peptide Shots in Brazil: The Hidden Risks for Expats
Foreign residents in Brazil face a growing grey market of unregulated injectable peptides. Here is what the health regulator Anvisa says about safety and legality.
7 min read
Beyond the Hype: Why Some Aren't Responding to GLP-1 Weight Loss Drugs
While GLP-1 agonists have revolutionized weight loss for many, a significant portion of individuals don't experience the same dramatic results. This article delves into the reasons behind GLP-1 non-response and offers guidance for those seeking effective weight management solutions.
7 min read
Ozempic, Wegovy, Mounjaro: Navigating the New GLP-1 Landscape
The landscape of GLP-1 medications for weight loss and chronic disease management is rapidly evolving. From new access programs to shifting pricing dynamics, understanding these advancements is crucial for patients and healthcare providers alike.
6 min read
Ozempic, Wegovy & Mounjaro: Weighing Risks for Young Patients on GLP-1s
As GLP-1 medications gain traction for weight management, doctors are increasingly prescribing them to adolescents. While short-term benefits are evident, significant questions remain about the long-term implications for young, developing bodies and minds.
7 min read
Beyond the Scale: Hunter McGrady on Inclusivity Amid GLP-1s
Hunter McGrady, a prominent plus-size model, shares her concerns about a cultural shift away from body inclusivity, fueled by the rise of GLP-1 medications. She argues that while these drugs can offer health benefits, the societal focus on weight loss over overall well-being is problematic.
7 min read
GLP-1s & Telehealth: Navigating Risks and Ensuring Safety
The booming popularity of GLP-1 medications for weight loss has coincided with a dramatic rise in telehealth services. This article delves into the benefits and significant risks of obtaining these powerful drugs online, highlighting critical safety concerns and offering guidance for patients.
6 min read
Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39
The journey to weight loss can be challenging, and for many, advanced medications like GLP-1 injectables offer a crucial pathway. However, their high cost often presents a significant barrier. Hers is changing this landscape by making popular GLP-1 and other weight loss treatments more accessible and affordable than ever before.
7 min read
Beyond Weight Loss: GLP-1 Drugs' Surprising Impact on Health
GLP-1 medications, initially developed for diabetes, are revolutionizing health outcomes, offering remarkable benefits for inflammation, joint pain, and even mental outlook, alongside significant weight loss.
8 min read
GLP-1 Therapies: Australia's New Blueprint for Obesity and Heart Health
Australia has released a groundbreaking clinical consensus statement on obesity and cardiovascular disease (CVD), marking a pivotal moment in medical practice. This new guidance places GLP-1 receptor agonists—a class of medications including semaglutide and tirzepatide—at the forefront of treatment strategies, offering clinicians a clear, practical pathway for improving patient outcomes.
6 min read
Beyond the Scale: Unpacking the 'Darth Vader' Effect of Rapid Weight Loss
A peculiar new side effect, dubbed the 'Darth Vader' effect, is emerging with rapid weight loss achieved through GLP-1 medications. This article delves into the phenomenon, its potential causes, and the critical need for a balanced approach to weight management.
7 min read
Ozempic, Mounjaro & More: Bridging the Global Gap for Cheaper Biologics
While generics have revolutionized drug affordability, newer biologics like those used for weight loss and diabetes face unique challenges. A new study reveals how varying international regulations are slowing the adoption of affordable biosimilars, impacting patient access and costs.
6 min read
Oral GLP-1s Enter the Ring: Early Trends Favoring Foundao Over Wegovy's Pill
The landscape of weight loss treatments is rapidly changing with the introduction of oral GLP-1 medications. This article delves into early adoption trends, comparing the initial uptake of Eli Lilly's oral semaglutide (Foundao) against Novo Nordisk's oral semaglutide (Wegovy's pill), and what these patterns signify for patients and physicians.
6 min read
Beyond the 'Bridal Glow': The Real Story of Mounjaro & Weight Loss
As 'Mounjaro brides' become a trend, an endocrinologist unpacks the medical realities, risks, and ethical concerns surrounding using powerful weight-loss medications for cosmetic pre-wedding transformations.
9 min read
Mounjaro, Wegovy & Hair Loss: Navigating the Side Effect and Regrowth
Rapid weight loss from GLP-1 medications can lead to temporary hair thinning. This article explores the causes of this common side effect and provides actionable advice for managing and encouraging hair regrowth, drawing on personal experiences and expert insights.
7 min read
Beyond the Hype: How GLP-1s Like Wegovy Are Reshaping Retail Spending
The growing popularity of GLP-1 medications, including Wegovy, is having a notable impact on retail spending, particularly in the pharmaceutical sector. This article delves into the economic implications and what it means for consumers and businesses.
6 min read
Michelle Obama's Weight: Addressing Speculation and GLP-1 Rumors
Recent public appearances by Michelle Obama have sparked widespread discussion about her appearance and weight. This article delves into the speculation, explores the role of GLP-1 medications in weight management, and discusses the broader implications of public observation on health and wellness.
6 min read
GLP-1s for Weight Loss: The NHS Two-Year Limit & Private Costs
As GLP-1 agonists revolutionize weight management, many patients face a critical juncture when NHS funding ends. This article delves into the realities of these powerful medications, the challenges of long-term access, and the growing divide between publicly funded care and private treatment costs.
7 min read
GLP-1 Drugs: Understanding the Weight Loss Revolution
The advent of GLP-1 receptor agonists has transformed the landscape of weight management, offering new hope for individuals struggling with obesity. This article delves into the science, benefits, potential drawbacks, and the leading players in this groundbreaking field.
7 min read
Looksmaxxing: The Risky Trend of Extreme Self-Improvement
Looksmaxxing, a trend focused on extreme self-improvement and physical optimization, has gained significant traction online. While some aspects involve standard grooming and fitness, others venture into dangerous territory, including bone-smashing and unregulated injectable substances. This article delves into the spectrum of looksmaxxing, its psychological underpinnings, and the serious health risks associated with its more extreme practices.
8 min read
Reclaiming Your Health: Beyond Weight Loss with GLP-1 Therapies
Explore the profound impact of GLP-1 medications, like semaglutide and tirzepatide, on not just weight management but also on reclaiming one's identity and overall health. Learn how these therapies can be a catalyst for significant life changes, as illustrated by personal journeys.
10 min read
Ryan Lochte Responds to 'Unrecognizable' Comments: Aging & Hair Dye
Olympic swimmer Ryan Lochte has responded to online speculation and comments suggesting he is 'unrecognizable.' He attributes the perceived changes to the natural process of aging and a recent, unexpected hair dye incident.
6 min read
PCOS Renamed PMOS: A New Era for Endocrine Health
Polycystic Ovary Syndrome (PCOS), a condition affecting millions of women, is undergoing a significant renaming to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change aims to better reflect the condition's complex interplay with endocrine and metabolic systems, potentially improving diagnosis and treatment.
8 min read
Peptide Use Among Young Men: The Pursuit of Perfection and Potential Risks
The quest for physical perfection is driving a new trend among teen boys and young men: the use of unapproved peptides. This article delves into the motivations, the substances involved, and the significant health concerns surrounding this practice.
8 min read
GLP-1 Medications: Understanding Ozempic, Wegovy, and Mounjaro
Celebrities and everyday individuals are increasingly discussing their experiences with GLP-1 medications such as Ozempic, Wegovy, and Mounjaro for weight management. This article delves into the science behind these popular drugs, their benefits, potential side effects, and what users can expect.
7 min read
GLP-1 Drugs & Kris Jenner: Why Some Find Them Difficult
Kris Jenner recently shared her experience with GLP-1 medications, revealing they made her feel unwell. This opens the door to understanding the nuances of these popular drugs and exploring alternative peptide therapies for weight management and overall health.
7 min read
Beyond 'Ozempic Face': Navigating Skin Changes After Weight Loss
Rapid weight loss, often aided by GLP-1 medications like Ozempic and Mounjaro, can lead to significant physical transformations. While celebrated, these changes can sometimes include unwelcome skin laxity, commonly referred to as 'Ozempic Face.' This article delves into the causes, expert opinions, and potential solutions for this growing concern.
9 min read
GLP-1 Peptides: Understanding Semaglutide, Tirzepatide & More
Discover the science behind GLP-1 peptides, including semaglutide and tirzepatide, and their transformative impact on weight management and metabolic health. Learn about popular medications and how they're changing the landscape of health tracking.
7 min read
GLP-1 Drugs and Hair Loss: What the Latest Research Reveals
New research suggests a connection between GLP-1 medications and temporary hair loss. Discover what this means for users of drugs like Ozempic, Wegovy, and Mounjaro, and how to navigate this common side effect.
8 min read
Online GLP-1 Programs: Revolutionizing Medically Supervised Weight Loss
Discover the seismic shift in obesity medicine as online GLP-1 programs leverage telehealth and advanced medications like semaglutide and tirzepatide to provide accessible, medically supervised weight loss solutions.
11 min read
GLP-1 Weight Loss Drugs: The Hidden Social Cost of Success
While GLP-1 medications offer a powerful new path to weight loss, emerging research reveals an unexpected challenge: intensified social stigma. This article explores the nuances of this phenomenon and its implications for patients.
7 min read
GLP-1 Agonists: Age Limits & Serious Risks of Weight Loss Drugs
This comprehensive guide delves into the critical considerations surrounding GLP-1 agonists for weight loss, addressing common concerns about age limits, potential risks, and practical advice for patients.
7 min read
GLP-1 Drugs: Reshaping Canada's Food Landscape and Consumer Habits
What began as a treatment for diabetes has rapidly evolved into a powerful force reshaping consumer behavior and Canada's agri-food economy. GLP-1 drugs are no longer niche medical interventions; they are becoming mainstream, driving significant changes in how Canadians eat and shop.
6 min read
Beyond Healthspan: The New Midlife Goal for Men
The traditional concept of retirement is being redefined as men in midlife increasingly focus on maintaining vitality and appearance, extending their 'hotspan' well into later years.
9 min read
GLP-1 Drugs & Your Health: Beyond Weight Loss & 'Ozempic Breath'
GLP-1 agonists are revolutionizing weight management, but their effects extend far beyond the scale. This article delves into the science, the side effects like 'Ozempic breath,' and how these powerful medications are reshaping consumer habits and personal health journeys.
7 min read
GLP-1 Drugs: Beyond Weight Loss – New Benefits and Risks Emerge
GLP-1 medications are revolutionizing weight management and diabetes care, but their impact extends far beyond the scale. This article delves into the emerging benefits and potential risks associated with these powerful drugs, offering a comprehensive overview for patients and healthcare providers.
8 min read
Beyond 'Ozempic Teeth': Understanding and Managing 'Ozempic Breath'
The rise of GLP-1 medications like Ozempic and Mounjaro has brought about new conversations around their side effects, including the emerging concern of 'Ozempic breath.' This article delves into the causes, implications, and effective management strategies for this common issue.
7 min read
Generic Semaglutide Approval in Canada: What It Means for Patients
Dr. Reddy's Laboratories has achieved a significant milestone by becoming the first company to receive market authorization from Health Canada for its generic semaglutide injection. This development promises to increase access to a crucial treatment option for Canadians.
6 min read
GLP-1 Medications: Miracle Drug, Wellness Trend, or Vanity?
GLP-1 medications have surged from diabetes treatment to mainstream wellness. This article examines their medical benefits, potential downsides, and the evolving societal perception of weight loss.
7 min read
India's 'Mounjaro Brides': Weight-Loss Injections in Pre-Wedding Prep
In India, 'Mounjaro brides' are using weight-loss injections as part of pre-wedding rituals, driven by intense societal expectations. Clinics like Klarity Skin Clinic offer specialized packages, while doctors report a surge in queries from brides and grooms. This trend highlights both the drugs' popularity and the need for medical supervision.
5 min read
RFK Jr. Plans to Unban 14 FDA-Banned Peptides, Tells Joe Rogan
RFK Jr. revealed on the Joe Rogan Experience his intent to lift FDA restrictions on 14 banned peptides from compounding pharmacies. This reversal addresses the late 2023 Category 2 list ban amid safety concerns and black market shifts. Patients and wellness advocates await formal decisions in coming weeks.
5 min read
Calgary Doctor Claims Generic Ozempic and Wegovy Drugs May Cut Costs by One-Third
According to a Calgary doctor, affordable generic alternatives to drugs like Ozempic and Wegovy might reduce expenses by up to a third. The content explores regional approaches to obesity management in Canada, emphasizing the challenges of rewiring brain circuitry and the role of medications in promoting healthier eating habits.
1 min read
Alicia Caiola, NY Medical Weight Loss Expert, Discusses GLP-1 Therapies
A recent article highlights key considerations for individuals seeking qualified medical weight loss providers, particularly concerning GLP-1 treatments. It stresses the importance of thorough evaluations, ongoing monitoring, and comprehensive plans for effective and sustainable weight management.
3 min read
Ozempic's Impact on American Food Purchasing Habits
New research reveals that medications like Ozempic are associated with considerable decreases in household food expenditures, both in grocery stores and restaurants. The study highlights how the adoption of GLP-1 drugs impacts daily food purchasing in real-world scenarios, showing a notable shift in consumer behavior.
4 min read
GLP-1 Weight Loss Breakthrough: Eli Lilly's $1.2B Investment & What It Means
Eli Lilly's significant investment in Puerto Rico aims to boost the production of oral GLP-1 medications, like orforglipron, for weight loss and other health benefits. This marks a turning point in accessible treatments for metabolic health. Dive into what this means for you and your wellness journey.
4 min read
The Dangers of Black Market Weight Loss Injections: Understanding GLP-1 and Staying Safe
This post explores the risks associated with black market weight loss injections, emphasizing the importance of safety and informed healthcare choices. Understanding the potential dangers of unregulated treatments, such as semaglutide, is crucial for your well-being.
4 min read